Document Detail


PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer.
MedLine Citation:
PMID:  18852081     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Colorectal cancer is a common malignancy that afflicts many in the western world. Imaging studies are frequently used to evaluate patients in the screening, staging and surveillance of colorectal cancer. Cross sectional imaging studies such as ultrasound, computed tomography and magnetic resonance imaging provide anatomic and morphologic information about tumor and patterns of spread. Positron emission tomography (PET) differs in that it provides information about tumor metabolism.[(18)F]Fluorodeoxyglucose PET has been clinically used for the evaluation of patients with a wide variety of cancers since most malignancies, including colorectal cancer, typically show increased glucose metabolism. This review present the positron emission tomography/computed tomography imaging findings that may be encountered in the diagnosis, staging and follow-up of patients with colorectal cancer.
Authors:
Raghu Vikram; Revathy B Iyer
Publication Detail:
Type:  Journal Article; Review     Date:  2008-10-04
Journal Detail:
Title:  Cancer imaging : the official publication of the International Cancer Imaging Society     Volume:  8 Spec No A     ISSN:  1470-7330     ISO Abbreviation:  Cancer Imaging     Publication Date:  2008  
Date Detail:
Created Date:  2008-10-14     Completed Date:  2008-11-14     Revised Date:  2010-10-05    
Medline Journal Info:
Nlm Unique ID:  101172931     Medline TA:  Cancer Imaging     Country:  England    
Other Details:
Languages:  eng     Pagination:  S46-51     Citation Subset:  IM    
Affiliation:
Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Colorectal Neoplasms / diagnosis,  pathology*
Fluorodeoxyglucose F18 / diagnostic use*
Follow-Up Studies
Humans
Neoplasm Staging
Positron-Emission Tomography / methods*
Tomography, X-Ray Computed / methods*
Chemical
Reg. No./Substance:
63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Staging rectal cancer: endoscopic ultrasound and pelvic MRI.
Next Document:  Promises and challenges of positron emission tomography for assessment of sarcoma in daily clinical ...